EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sareum Holdings's enterprise value is £37.37 Mil.
Sareum Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil. Therefore, Sareum Holdings's EV-to-Revenue for today is .
The historical rank and industry rank for Sareum Holdings's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Sareum Holdings was 5761.31. The lowest was 102.53. And the median was 1321.45.
LSE:SAR's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.18 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-25), Sareum Holdings's stock price is £0.35.
Sareum Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00. Therefore, Sareum Holdings's PS Ratio for today is .
Sareum Holdings EV-to-Revenue Historical Data
The historical data trend for Sareum Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sareum Holdings's EV-to-Revenue
For the Biotechnology subindustry, Sareum Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sareum Holdings's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sareum Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Sareum Holdings's EV-to-Revenue falls into.
Sareum Holdings's current Enterprise Value is £37.37 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sareum Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sareum Holdings's share price for today is £0.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sareum Holdings EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Sareum Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:SAR has been successfully added to your 